This Week in Psychedelics - 3.18.22

Cannabis

• Israeli Town of Tira Founds First Medical Cannabis Cafe (High Times)

• Kentucky House Passes Medical Marijuana Legalization Bill (Marijuana Moment)

• Delaware House Shoots Down Recreational Legalization Bill (High Times)

• New VA Veteran Suicide Program Won’t Allow Cannabis as Treatment (High Times)

• Mike Tyson's cannabis brand is making ear-shaped weed gummies (NBC News)

• Marijuana Legalization Hasn’t Led To More Youth Use, Report From Alcohol And Tobacco Industry-Backed Group Says (Marijuana Moment)

• Oklahoma Thieves Impersonate Cops and Raid Several Pot Farms (High Times)

• Alabama Bill Would Force Women Who Want Medical Marijuana To Show Negative Pregnancy Tests (Marijuana Moment)

• Montana Supreme Court OKs Temporary Rules For Cannabis Expungement (High Times)

• New Orleans City Council Urges End To Marijuana Testing For Government Employees (Marijuana Moment)

• Georgia Lawmakers Consider Separate Medical Cannabis Production Bills (High Times)

• Some Mississippi Cities Move To Ban Medical Marijuana Businesses (Marijuana Moment)

• European Commission Sets Standards for Hemp Food (High Times)

• Jones Soda Company Announces Cannabis-Infused Product Line (High Times)

LSD

• Montreal researchers find that, like Prozac, LSD may be useful for anxiety treatment (CTV News)

• Novamind to Host MindMed Phase IIb Trial for LSD and Anxiety (BioSpace)

Magic Mushrooms

• California Activists Drop 2022 Psilocybin Legalization Ballot Initiative After Falling Short Of Signature Requirement (Marijuana Moment)

• Little evidence on how psilocybin therapy interacts with existing psychiatric treatments, review finds (OHSU News)

• California Psychedelics Investors Are Closely Monitoring Oregon’s Psilocybin Market (Willamette Week)

• Washington State Legislature Approves $200,000 In Psilocybin Research Funding In Budget (Marijuana Moment)

• Novamind announces phase 2 trial examining psilocybin for MDD (Healio)

• Psilocybin Is The Most Studied Psychedelic (Green Market Report)

MDMA

• MDMA-assisted psychotherapy for PTSD could save the health care system millions of dollars, study suggests (PsyPost)

• Dose-ranging study provides insight into MDMA’s effects on memory, addiction, and depression (PsyPost)

Ayahuasca

• Federal judge dismisses ayahuasca church’s request for overturn of DEA decision (WFTV)

• Study will investigate ayahuasca to overcome prolonged grief (Ruetir)

• Controversy Over Injustice Against Ayahuasca Traditional Knowledge Rebounds (Chacruna)

Ketamine

• A Ketamine Clinic Treads the Line Between Health Care and a ‘Spa Day for Your Brain’ (The New York Times)

Miscellaneous

• Connecticut Lawmakers Approve Bill To Fund Psilocybin And MDMA Therapy (Marijuana Moment)

• Students Launch Bid to Decriminalize All Drugs in Ann Arbor, Michigan (Filter)

• New Research Explores Whether Therapeutic Psychedelics Can Fix ‘Biophobia’ (Forbes)

• Keywords from hallucinogenic experiences can help find parts of the brain affected by drugs (The Verge)

• Feds Reveal Which Industries Drug Test Workers The Most And Least In New Report (Marijuana Moment)

• MDMA use drops due to COVID lockdowns, other drugs rise -EU report (Reuters)

• What do psychedelic drugs do to our brains? AI could help us find out (MIT Technology Review)

• How Can We Apply Harm Reduction to HPPD? (Psychedelics Today)

• Colorado Activists Pick One Of Several Psychedelics Reform Initiatives To Pursue For November Ballot (Marijuana Moment)

• London should pilot drug checking and consumption rooms, says report (London Evening Standard)

• Current Psychedelic Therapies Use Flawed Models of the Mind – It’s Time for Relational Therapy (Healing Maps)

• Mind Cure Health Halts All Psychedelic Business Activity (Psychedelic Spotlight)

• Are drug wars protection rackets? (Drug WarRant)

• Microdosing Is On The Rise But Is It Healthy? (The Dales Report)

• Terence McKenna’s Anarchic Psychedelic Religion (JSTOR Daily)

• Coming of Age in the Psychedelic Sixties (Chacruna)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 11.19.21

Cannabis

• U.S. Republicans move to decriminalize marijuana at federal level (Reuters)

• Germany Set To Legalize Marijuana Nationwide After Major Parties Reach Agreement (Marijuana Moment)

• Brazil is on The Brink of Medical Cannabis Change (High Times)

• Is This The First Real Case Of Fentanyl-Tainted Marijuana In The U.S.? (Forbes)

• Indiana Democratic Party Backs Marijuana Legalization And Pledges 2022 Reform Push (Marijuana Moment)

• New York Senator Files Bill To Extend Marijuana Equity Benefits To Transgender And Non-Binary People (Marijuana Moment)

• Straws Lined with THC Could Transform Edibles Industry (High Times)

• Bipartisan Wisconsin Lawmakers Unveil Marijuana Decriminalization Bill (Marijuana Moment)

• New study shows no increase in car crash injuries after marijuana legalized (Vancouver Sun)

• Canadian Groups Gives Free Weed And Edibles To Fight Opioid Abuse (High Times)

• Marijuana Legalization Attitudes Vary Significantly Within Partisan Coalitions, Pew Survey Shows (Marijuana Moment)

• Creating a better cannabis cultivation facility while strengthening relationships with third-party testing labs (Marijuana Business Daily)

• Sturdy Hemp Structures Could be the Future Eco-Building (High Times)

• Using cannabis in pregnancy linked to aggression and anxiety in children, a study suggests (CNN)

• Study: Scarification of cannabis seeds, certain disinfectants boost germination rates (Marijuana Business Daily)

LSD

• MindMed Launches Study of Low-Dose LSD Effects on Sleep and Cognitive Measures (Psilocybin Alpha)

• Up, Up and Away: The Trippy Tales Behind ‘Flying Over Sunset’ (The New York Times)

• Is LSD Safe - Latest Research Findings (Drug Science)

• The LSD Comedown: Navigating the After Effects of Acid (DoubleBlind)

Magic Mushrooms

• Bill on magic mushrooms aims to make Pa. a national leader in psychedelic research (The Philadelphia Inquirer)

• NYC Subways Ban Marijuana And Psychedelic Mushroom Ads (Marijuana Moment)

• Magic Mushrooms, A Love Story (The New Yorker)

• PharmaTher Announces Positive Research Results for Psilocybin Microneedle Patch (Psilocybin Alpha)

• Tryp Therapeutics Provides Update on Clinical Hold for Phase 2a Study for Eating Disorders (Yahoo!)

• TheraPsil and Imperial College London, McGill University Partner on Psilocybin Study (Truffle Report)

• Red Light Holland Psilocybin Truffles, Sold in The Netherlands, Complete First Evaluation Under a Health Canada Approved cGMP Laboratory (Psilocybin Alpha)

• Another Life: Foraging for mushrooms and natural psychedelics (The Irish Times)

MDMA

• World's 'Strongest-Ever' Ecstasy Pill Found in English Nightclub (VICE)

DMT

• Algernon Announces Positive Feedback on its Planned Phase 1/2a DMT Human Stroke Study (Yahoo!)

• Discussions With FDA Provide Guidance for Phase IIb Clinical Trial Design for DMT-Assisted Therapy for Major Depressive Disorder (Psilocybin Alpha)

Ayahuasca

• Is This Phoenix Pastor a Spiritual Shaman or an Ayahuasca Kingpin — or Both? (Phoenix New Times)

• Ron White’s strange ayahuasca experience, as described on JRE. (Ceng News)

5-MeO-DMT

• Mike Tyson ‘died’ while tripping on psychedelic toad venom (New York Post)

• Biomind Labs Completes Development of a Thermosensitive Nasal Gel Pharmaceutical Dosage Form (Business Wire)

Novel Psychoactive Substances

• New Psychedelic Molecules: What’s in Development? (Truffle Report)

• New Psychedelic Molecules Part II: Key Industry Players (Truffle Report)

• Researchers train computers to predict the next designer drugs (ScienceDaily)

• BetterLife Pharma says pharmacology data on second-generation LSD derivative confirms its projected non-hallucinogenic property (Proactive Investors)

Ketamine

• Michael J. Fox Foundation Grant Will Fund First Clinical Trial of Ketamine to Treat Depression in People with Parkinson’s Disease (Yale School of Medicine)

• Warning of ‘wild west’ in depression treatment as UK clinics offer ketamine (The Guardian)

• Bexson Biomedical Announces Expansion to Treat Major Depression with Wearable Ketamine Formulation (PR Newswire)

• Silo Pharma and Strategic Partner Zylo Therapeutics Begin Development Process for Novel Ketamine Loaded Z-Pods (Psilocybin Alpha)

DXM

• Teenagers are ‘robotripping’ in the pursuit of cheap highs, again (Screenshot Media!)

Miscellaneous

• Jon Hopkins’s Psychedelic Journey to a New Way of Creating Music (The New York Times)

• "Aharon said it was healing:" How psychedelic therapy was undermined by abuse (Inverse)

• Psychedelics Use Associated With 55 Percent Decrease In Daily Opioid Consumption, Study Finds (Marijuana Moment)

• Horizons Conference Reconvenes in NYC to Connect Psychedelic Communities (Lucid News)

• New Non-Profit Supports Groundbreaking HPPD or ‘Acid Flashback’ Research (Truffle Report)

• Inside The Race To Create A Two-Hour Psychedelic Therapy Experience (Forbes)

• Psychedelics Help Heal Childhood Trauma, Study Finds (Benzinga)

• Psychedelic Bypassing: When Avoidance is Mistaken for Healing (Psychedelics Today)

• Canadian Biotech Known For Psilocybin And Cannabinoid-Based Medicines In FDA Phase 3 Trial For Bucillamine-Based Oral Covid Treatment (Forbes)

• Three Decades of Drug Policy Reform Work (Open Society Foundations)

• A Close Reading of the QAnon Shaman’s Conspiracy Manifesto (Lit Hub)

• Naropa University Announces Psychedelic-Assisted Therapies Certificate (Tricycle)

• A New Psychedelic Organization is Merging Shamanism and Science (Lucid News)

• The Serotonin 5-HT2A Receptor: From Mice to Humans (Psychedelic Science Review)

• Animals That Eat Psychedelics and Enjoy the Trip (Psychedelic Spotlight)

• CaaMTech Teams Up With University of Wyoming to Study Psychedelics as Treatments for Addiction (Psilocybin Alpha)

• MYND Diagnostics Commences Clinical Research on Alzheimer’s Disease (Psilocybin Alpha)

• Letting people test their drugs will reduce the number of needless deaths (The Independent)

• The History of Psychedelics: An ancient tradition (Canex)

• MYND Diagnostics Commences Clinical Research on Multiple Sclerosis Biomarker Test (Psilocybin Alpha)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalog how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 12.4.20

Cannabis

• House Approves Federal Marijuana Legalization Bill In Historic Vote (Marijuana Moment)

• U.N. Reclassifies Cannabis as a Less Dangerous Drug (The New York Times)

• MORE Act Approved by House Rules Committee (NORML)

• These States Could Have Marijuana Legalization On Their 2022 Ballots (Marijuana Moment)

• Arizona: Prop. 207 Legalization Measure Officially Takes Effect (NORML)

• CBD Doesn’t Impair Driving, Landmark Study Finds, While THC’s Effects Fade In Hours (Marijuana Moment)

• DEA Asks Federal Court To Dismiss Marijuana Rescheduling Lawsuit—Again (Marijuana Moment)

• Lawsuit Filed Against the DEA and Attorney General to Compel Issuance of Licenses to Manufacture Marijuana for Clinical Trials and Potential FDA Approval (MAPS)

• The Future Of The Cannabis Industry After The Pandemic (Forbes)

• “No Evidence” that Adult-Use Marijuana Laws Influence Cannabis Use by Teens (NORML)

• What History Teaches Us About Shaping South Africa's New Cannabis Laws (TalkingDrugs)

• How pagans used cannabis at Christmastime (Leafly)

LSD

• ‘We have a drug problem’: Camp Lejeune starts random LSD testing (Stars and Stripes)

• Silo Pharma Announces Plans for a Phase 2B Investigator Lead Study Using Psychedelics Psilocybin and Lysergic Acid Diethylamide (“LSD”) to Treat Parkinson’s Disease (Psilocybin Alpha)

• I'm an 'LSD Specialist' Who Sells Acid to Oxford University Students (VICE)

Magic Mushrooms

• Oregon Governor Takes First Step To Regulate Psilocybin Mushroom Therapy By Forming New Board (Marijuana Moment)

• Understanding The Psilocybin Supply Chain: Every Production Method Explained (Yahoo! Finance)

MDMA

• Numinus and MAPS Public Benefit Corporation announce collaboration agreement to seek approval of MDMA-assisted psychotherapy for PTSD single-arm, open-label trial (Psilocybin Alpha)

DMT

• Entheon Biomedical Announces CRO Agreement with CHDR for Phase 1 Clinical Trial; Centre for Human Drug Research Led DMT Study to Start in 2021 (Psilocybin Alpha)

Ayahuasca

• Coronavirus and Evolving Ceremonial Practice Among Ayahuasca Practitioners in the US (Chacruna)

• Ayahuasca, Healing and Cognitive Justice (Chacruna)

5-MeO-DMT

• Mike Tyson credits toad venom for his return to boxing ring (New York Post)

Salvia Divinorum

• New research shows a link between Salvinorin A and the DMN (The Psychedelic Scientist)

Novel Psychoactive Substances

• CaaMTech Researchers Synthesize and Structurally Characterize Deprocin Hydrochloride (Psilocybin Alpha)

• Tackling the Global Issue of New Psychoactive Substances (News-Medical.net)

Ketamine

• Ketamine-Assisted Psychotherapy – Online? (Psychedelic Support)

Miscellaneous

• Where Will Psychedelics and Other Drugs Be Decriminalized Next? (DoubleBlind)

• 'Sistine Chapel of the ancients' rock art discovered in remote Amazon forest (The Guardian)

• New Study Identifies Link Between Personality Traits And Psychedelic Experiences (IFLScience)

• Leaked FBI Report: Drug Sellers Practice Harm Reduction (Filter)

• What will 'psychedelic therapy' look like when it's legalized? (Big Think)

• How Do American Psychiatrists View Psychedelics? (Psychedelic Support)

• How Are Psychedelics Companies Generating Revenue Before Legalization? (Microdose)

• Psychedelics, Masculinity, and Mental Health (Sam Woolfe)

• “Please Write Up Your Work!”: Laura Archera Huxley as a Psychedelic Pioneer (Chacruna)

• A Sub-Perceptual Promise: Can Microdosing Solve Mainstream Problems? (The Third Wave)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.

This Week in Psychedelics - 6.12.20

Cannabis

• Government announces plan to advance cannabis legalization reforms (The Times of Israel)

• Bermuda Has Officially Proposed a Framework to Legalize Adult-Use Cannabis (MERRY JANE)

• New lawsuit aims to force DEA to reschedule marijuana (Leafly)

• Effects of cannabis edibles can vary greatly based on small differences in THC dose (PsyPost)

• Kansas Medical Marijuana Bill Dies In Committee After Special Session Ends (Marijuana Moment)

• Oregon Cannabis Association Demands Portland Cannabis Tax Not Be Used on Law Enforcement (Cannabis Business Times)

• NBA Players Union Head Joins Marijuana Company As League Reportedly Suspends Drug Testing (Marijuana Moment)

• NORML Letter to NIDA: Prohibition Must Be Recognized as More Damaging than Marijuana Itself (NORML)

• Here’s how to start fixing racism in cannabis dispensaries (Leafly)

• Nevada Governor Introduces Measure To Pardon Tens Of Thousands With Marijuana Convictions (Marijuana Moment)

• South Dakota Voters Could Make Cannabis History in November (Cannabis Wire)

• Providing the Legitimacy of Cannabinoids for the Treatment of Cancer (Onco'Zine)

• Cannabis temporarily reduces severity of PTSD symptoms (News-Medical.net)

• Do Highly Potent Marijuana Concentrates Get Users More High? Not Exactly, Study Finds (Marijuana Moment)

• Ultra-low cannabis dosing: When microdosing is still too much (Leafly)

• 5 Signs of Using Cannabis Too Frequently (Psychology Today)

LSD

• Phase 2 Clinical Trial of LSD for "Suicide Headaches" Begins Treating Patients (PR Newswire)

Magic Mushrooms

• Champignon Identifies Synthetic Ketamine and Psilocybin/Psilicin Metabolite Targets; Selects Dalriada to Advance NCE IP Portfolio (Globe Newswire)

• Rapid Therapeutic Explores Treatment of Anxiety Utilizing Proprietary Delivery System for Psilocybin and CBD (Globe Newswire)

• Dog rushed to vet after it eats human poo filled with magic mushrooms at beach (Daily Star)

MDMA

• Impressive long-term benefits of MDMA for treating PTSD, study reports (New Atlas)

• Is MDMA Neurotoxic? (Spirit Pharmacist)

DMT

• I Sell DMT Vape Pens So People Can 'Break Through' at Their Own Speed (VICE)

• Beyond Ayahuasca: Therapeutic Effects of N,N-Dimethyltryptamine (DMT) (Psychedelic Science Review)

• Former UFC Champion Henry Cejudo Details DMT Experience With Mike Tyson (MMA News)

Ayahuasca

• Not All Ayahuasca is Made Equal (Psychedelics Today)

• What if a Shaman Could Solve All Your Problems, in Three Days? (The New York Times)

Iboga

• Powerful psychedelic drug ibogaine could help people kick opioid addictions (Genetic Literacy Project)

Synthetic Cannabinoids

• Drug trial planned for synthetic cannabinoid coronavirus treatment (Chicago Tribune)

Nitrous Oxide

• No laughing matter: new legislation will ban the sale of nitrous oxide (DutchNews.nl)

Ketamine

• US customs officers find ketamine smuggled inside paintings of Jesus Christ (Mixmag)

• High doses of ketamine can temporarily switch off the brain (ScienceDaily)

Miscellaneous

• How the Psychedelic Movement Can Support Black Lives Matter (DoubleBlind)

• Protests Drive DC Psychedelics Decriminalization Signatures As Activists Launch Major Mailer Campaign (Marijuana Moment)

• We can no longer ignore the potential of psychedelic drugs to treat depression (The Guardian)

• Children and Psychedelics: Using Indigenous Wisdom to Examine Western Paradigms (Chacruna)

• How the War on Drugs Enables Police Brutality Against Black People (VICE)

• Colonial Shadows in the Psychedelic Renaissance (Chacruna)

• Help Decriminalize Nature Canada Petition the Canadian Government to Decriminalize Psychedelic Plants (Psychedelic Times)

• Are deep psychedelic experiences trustable? An exchange between Ken Ring and Chris Bache (Medium)

• The Power of Psychedelic Communities, Through the Lens of an Activist POTC (Lucid News)

• What Do Psychedelic Medicine Companies Owe to the Community? (Chacruna)

• Legal Highs: The Top Legal Psychoactive Plants in the US and Canada (DoubleBlind)

• Psychedelic Leadership Community Build at Psychedelic Liberty Summit (Chacruna)

• The Psychedelic Designs of Adam Nathaniel Furman (Sam Woolfe)

• Psychedelics Seek to Emulate Cannabis' Rise to Social Acceptance (New Kerala)

• PSYC Expanding Their Global Reach To Showcase Psychedelic Industry Leaders and Pioneers (Globe Newswire)

Think Wilder is reader-supported. If you enjoyed this week’s update, please consider helping out by becoming a patron, making a one-time donation, or sharing this post with a friend. Thank you for your support.

Disclaimer: "This Week in Psychedelics" does not censor or analyze the news links presented here. The purpose of this column is solely to catalogue how psychedelics are presented by the mass media, which includes everything from the latest scientific research to misinformation.